Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of Duodenal Exclusion for the Treatment of Type 2 Diabetes (T2DM)

NCT00534547 is registered in ClinicalTrials.gov with Medtronic - MITG as lead sponsor.

NCT NCT00534547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00534547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of Duodenal Exclusion for the Treatment of Type 2 Diabetes (T2DM)
Lead sponsor
Medtronic - MITG
Phase
Not applicable
Overall status
Withdrawn
Start date
Not reported
Completion date
Not reported
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes